Monitoring Complement Activation: The New Conundrum in Thrombotic Microangiopathies. [PDF]
Fakhouri F, Frémeaux-Bacchi V.
europepmc +1 more source
Complement activation in thrombotic thrombocytopenic purpura [PDF]
Alvarez-Larran +28 more
core +1 more source
High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.
Fengxiao Bu +15 more
semanticscholar +1 more source
Thrombotic microangiopathies: Similar presentations, different therapies
G. Appel
semanticscholar +1 more source
Complement, thrombotic microangiopathy and disseminated intravascular coagulation [PDF]
core +1 more source
HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies. [PDF]
Pandey S +4 more
europepmc +1 more source
When to consider targeted therapies in thrombotic microangiopathies in the modern era: walking the tightrope between cost, safety, and efficacy. [PDF]
Murphree CR +3 more
europepmc +1 more source
Unfavorable course in pregnancy-associated thrombotic thrombocytopenic purpura necessitating a perimortem Cesarean section: a case report [PDF]
core +1 more source

